NEETPGAI
BlogComparePricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Previous Year Questions
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Pathology/Hepatitis — Viral
    Hepatitis — Viral
    hard
    microscope Pathology

    A 35-year-old man from Mumbai with a 15-year history of hepatitis B (HBeAg positive, HBV DNA 8 × 10^5 copies/mL) presents with acute onset jaundice, right upper quadrant pain, and fever. Laboratory findings: total bilirubin 6.5 mg/dL, ALT 4200 IU/L, AST 3800 IU/L, albumin 3.2 g/dL, INR 1.3. Serological testing shows HBsAg positive, anti-HBc positive, HBeAg positive, anti-HBe negative, anti-HAV IgM negative, anti-HCV negative. Abdominal ultrasound shows hepatomegaly with normal portal vein flow. What is the most likely diagnosis?

    A. Fulminant hepatitis B with cirrhosis
    B. Acute hepatitis A superinfection on chronic hepatitis B
    C. Acute exacerbation of chronic hepatitis B
    D. Hepatitis B surface antigen mutant with immune escape

    Explanation

    ## Clinical Diagnosis: Acute Exacerbation of Chronic Hepatitis B ### Distinguishing Acute Exacerbation from Superinfection **Key Point:** The absence of anti-HAV IgM and the presence of HBsAg + anti-HBc (markers of chronic HBV) confirm this is an acute exacerbation of pre-existing chronic hepatitis B, NOT a new superinfection. | Feature | Acute Exacerbation | HAV Superinfection | HEV Superinfection | |---------|-------------------|-------------------|--------------------| | HBsAg | Positive | Positive | Positive | | Anti-HBc | Positive (IgG) | Positive (IgG) | Positive (IgG) | | Anti-HAV IgM | Negative | **Positive** | Negative | | Anti-HEV IgM | Negative | Negative | **Positive** | | HBeAg | May be positive or negative | Positive (if HBeAg+ before) | Positive (if HBeAg+ before) | | Mechanism | Immune flare of existing HBV | New HAV infection on HBV | New HEV infection on HBV | **This patient:** Anti-HAV IgM **negative** → rules out HAV superinfection. ### Pathophysiology of Acute Exacerbation **High-Yield:** Acute exacerbations of chronic HBV occur due to: 1. Spontaneous immune flare (HBV-specific CD8+ T-cell activation) 2. Viral reactivation (e.g., after immunosuppression withdrawal) 3. Emergence of HBeAg-negative mutants 4. Superinfection with HDV (hepatitis D) This patient's **HBeAg-positive status with high HBV DNA** suggests active viral replication with an acute immune response. ### Clinical Features Supporting Exacerbation (NOT Fulminant Failure) **Clinical Pearl:** Although INR is mildly elevated (1.3), this patient does NOT meet criteria for fulminant hepatic failure: - INR 1.3 is only mildly elevated; fulminant failure requires INR > 1.5 - Albumin 3.2 g/dL is low-normal, not severely depleted - No mention of encephalopathy or asterixis - Normal portal vein flow on ultrasound (no portal hypertension/cirrhosis) These findings indicate **acute exacerbation with preserved hepatic reserve**, not fulminant failure. ### Serological Interpretation Algorithm ```mermaid flowchart TD A["HBsAg positive?"]:::decision A -->|Yes| B["Anti-HBc positive?"]:::decision A -->|No| Z["Not HBV"]:::outcome B -->|Yes| C["Chronic HBV"]:::outcome B -->|No| D["Acute HBV"]:::outcome C --> E["Anti-HAV IgM positive?"]:::decision E -->|Yes| F["HAV superinfection"]:::outcome E -->|No| G["Acute exacerbation of chronic HBV"]:::outcome D --> H["Check anti-HBc IgM"]:::action ``` ### Management Implications **Mnemonic: CARE** — Consider Antivirals, Rule out complications, Evaluate synthetic function, Exclude superinfections Acute exacerbations of chronic HBV are managed with: - Supportive care (most resolve spontaneously) - Antiviral therapy if INR > 1.5 or encephalopathy develops - Monitoring for fulminant progression - Screening for HDV superinfection (anti-HDV) [cite:Harrison 21e Ch 360; Robbins 10e Ch 18]

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Pathology Questions